Know Mesothelioma Facts & Help

Mesothelioma Facts & Statistics
Subscribe

Input code on Theme Options

3 Potential Peritoneal Mesothelioma Symptoms

November 21st, 2010 by ajmal | No Comments | Filed in Mesothelioma Treatments

Article by Tom Parker

Mesothelioma is one of the less common types of cancer affecting around 2000 people in the UK each year. It develops when the linings of the lungs or the abdomen start to grow in a rapid and uncontro ...Read More

Tags: , , ,

Finding the Right Texas Mesothelioma Attorney

November 20th, 2010 by ajmal | No Comments | Filed in Mesothelioma Survival Rate

Mesothelioma is a malignant form of cancer that affects the mesothelium, which is the inner lining of the internal organs of the body such as the heart and abdomen. People who work in manufacturing industries that use asbestos in any amounts may be at risk for contracting this type of cancer. The latency period of this type of cancer is often very long. The latency period refers to the time between the exposure to asbestos and the surfacing of symptoms of cancer. Statistics have shown that many people who exhibit signs and symptoms of this type of cancer may have been exposed to asbestos at the workplace more than a decade earlier. Since laws regarding asbestos cancer cases are different among the states, along with variations in their statutes of limitation, winning an asbestos-related lawsuit can be difficult..

...Read More

Tags: , , , ,

Symptoms of Mesothelioma

November 13th, 2010 by ajmal | No Comments | Filed in Mesothelioma Statistics & Facts

The term “Mesothelioma” in medical terms is defined as form of cancer that proliferates at a very fast rate after it has been diagnosed, which affects the mesothelial cells in the body. After detailed study of this disease by several scientists all over the world, it has been concluded that in most of the cases the reason is the direct contact with loose asbestos particles. This disease is generally known to be derived from an abnormality that arises from inhaling the loose asbestos particles suspended in the air for a very long time. The chances of the patients, diagnosed of mesothelioma, have very bleak chances of survival which is not more than one or two years and if it has been detected long back and rigorous medication has been started on the patient then the patient is likely to live for about five years.


There are three types of mesothelioma but the sympto ...Read More

Tags: ,

Mesothelioma Asbestos Lawyer – A history of a Malignant Industry and How You Can Receive Compensation

November 11th, 2010 by ajmal | No Comments | Filed in Uncategorized

Article by Paul J. Folkmann

The history of asbestos dates back to around 2000 thousands years ago. However, it may surprise you to know that the dangers of asbestos have been known as far back as the Roman empire, when it was linked to lung disease in the slaves that were forced to mine the mineral for commercial use.

In more recent history, in 1918, the U.S. Bureau of Labour Statistics published a report that linked the deaths of asbestos workers to the inhalation of asbestos.

Then in 1924, a 33 year old woman named Nellie Kershaw died from the world’s first diagnosis of asbestosis in the UK. She worked in an asbestos plant for the world’s largest asbestos conglomerate named Turner & Newall (T&N). T&N denied any responsibility or compensation. Decades later, documents at the Manchester Metropolitan University exposed the scandalous fact tha ...Read More

Tags: , , , , , , ,

Mesothelioma Progression and Evaluation

November 9th, 2010 by ajmal | No Comments | Filed in Mesothelioma Survival Rate

Another interesting study is called, “Pemetrexed as Second-Line Treatment in Malignant Pleural Mesothelioma after Platinum-Based First-Line Treatment” by Sørensen, Jens Benn MD, DMSc, MPA; Sundstrøm, Stein MD, DMS; Perell, Katharina MD; Thielsen, Anne-Kathrine MD – Journal of Thoracic Oncology: February 2007 – Volume 2 – Issue 2 – pp 147-152.  Here is an excerpt: “Abstract – Introduction: Pemetrexed is active as first-line treatment of malignant pleural mesothelioma. The objective was to evaluate its activity as second-line treatment.  Methods: Patients had disease progression of malignant pleural mesothelioma after previous platinum-based regimens without pemetrexed. Treatment was pemetrexed alone or pemetrexed combined with carboplatin. Pemetrexed dosing was 500 mg/m2 and carboplatin was AUC (area under the curve) 5 once every 3 week ...Read More

Tags: , ,